← back to search

Regine Mayer‐Steinacker

University Hospital Ulm ·
Area of research
Pulmonary and Respiratory Medicine · Molecular Biology
Research interest
Research interests include Advanced Breast Cancer Therapies, Sarcoma Diagnosis and Treatment, Protein Degradation and Inhibitors, and Glioma Diagnosis and Treatment.
h-index
25
citations
3,742
works
96
NIH funding
primary concept
email

Recent publications

Prognostic factors for overall survival in elderly patients with glioblastoma: Analysis of the pooled NOA-08 and Nordic trials with the CCTG-EORTC (CE.6) trial
Neuro-Oncology Advances 2024cited by 4position: middledoi
Systematic symptom screening in patients with advanced cancer treated in certified oncology centers: results of the prospective multicenter German KeSBa project
Journal of Cancer Research and Clinical Oncology 2023cited by 26position: middledoi
Superiority of temozolomide over radiotherapy for elderly patients with RTK II methylation class, MGMT promoter methylated malignant astrocytoma
Neuro-Oncology 2020cited by 73position: middledoi
Neurocognitive functioning and health-related quality of life in adult medulloblastoma patients: long-term outcomes of the NOA-07 study
Journal of Neuro-Oncology 2020cited by 26position: middledoi
U-DCS: characterization of the first permanent human dendritic sarcoma cell line
Scientific Reports 2020cited by 3position: middledoi
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort
European Journal of Cancer 2019cited by 718position: middledoi
Multicenter pilot study of radiochemotherapy as first-line treatment for adults with medulloblastoma (NOA-07)
Neuro-Oncology 2017cited by 88position: middledoi
A randomized exploratory phase 2 study in patients with chemotherapy-related peripheral neuropathy evaluating whole-body vibration training as adjunct to an integrated program including massage, passive mobilization and physical exercises
Experimental Hematology and Oncology 2017cited by 62position: middledoi
Therapy for Recurrent High-Grade Gliomas: Results of a Prospective Multicenter Study on Health-Related Quality of Life
World Neurosurgery 2017cited by 23position: middledoi
Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O<sup>6</sup>-Methylguanine–DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial
Journal of Clinical Oncology 2016cited by 196position: middledoi
Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial
The Lancet Oncology 2012cited by 1,120position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Guido Reifenberger · University of Toronto2 papers (2012–2020) · 2 papers (2012–2020)Michael Weller · Center for Neurosciences2 papers (2012–2020) · 2 papers (2012–2020)Ralf Ketter · Saarland University2 papers (2012–2020)Jörg Felsberg · Düsseldorf University Hospital2 papers (2012–2020)Michael Platten · German Cancer Research Center2 papers (2012–2020)Joachim P. Steinbach · Goethe University Frankfurt2 papers (2012–2020)Michael Sabel · Düsseldorf University Hospital2 papers (2012–2020)Wolfgang Wick · Heidelberger Institut für Radioonkologie2 papers (2012–2020)Christoph Meisner · University of Regensburg2 papers (2012–2020)Jürgen Meixensberger · University Hospital Leipzig2 papers (2012–2020)Mirjam Renovanz · University Children's Hospital Tübingen1 papers (2017–2017) · 1 papers (2020–2020) · 1 papers (2020–2020) · 1 papers (2017–2017) · 1 papers (2017–2017)Anne‐Katrin Hickmann · LMU Klinikum1 papers (2017–2017) · 1 papers (2020–2020) · 1 papers (2020–2020)